Elhassan Mahmoud

Elhassan Mahmoud

Auto-generated profile, based on publicly available information

Elhassan Mahmoud

Hamad Medical Corporation

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
EMElhassan Mahmoud
Elhassan Mahmoud
AEAbdalla Moustafa Elsayed
Abdalla Moustafa Elsayed
BEBasant Moustafa Elsayed
Basant Moustafa Elsayed
YEYasmin Elsalakawi
Yasmin Elsalakawi
AGAswathy Gopinath
Aswathy Gopinath
TCTawanda Chivese
Tawanda Chivese
Objectives To quantify the association between Gestational Diabetes Mellitus (GDM) and adverse pregnancy outcomes and primarily compare the associations between diagnostic criteria following the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations and non-IADPSG criteria, which use higher blood glucose cut-offs. Design Systematic review and meta-analysis of observational studies using contemporary GDM diagnostic criteria. Data sources PubMed, Scopus, Google Scholar, Cochrane Database of Systematic Reviews and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched for articles published between 2010 and 2023. The search was carried out on 15 May 2023. Eligibility criteria Studies were included if they were observational studies that reported adjusted effect sizes for GDM-related adverse outcomes and compared outcomes between women with and without GDM, used contemporary diagnostic criteria and were conducted after 2010. Data extraction and synthesis Two reviewers independently extracted data and assessed study quality using the MethodologicAl STandards for Epidemiological Research (MASTER) scale. Bias-adjusted inverse variance heterogeneity meta-analysis models were used to synthesise adjusted effect sizes. The same meta-analytic models were used to synthesise the overall OR and their 95% CIs for comparisons of the criteria which followed the IADPSG recommendations to other criteria, mostly with higher blood glucose cut-offs (non-IADPSG). Results We included 30 studies involving 642 355 participants. GDM was associated with higher odds of maternal outcomes, namely; caesarean section (adjusted OR (aOR) 1.24, 95% CI 1.01 to 1.51) and pregnancy-induced hypertension (aOR 1.55, 95% CI 1.03 to 2.34). GDM was associated with higher odds of neonatal outcomes, specifically; macrosomia (aOR 1.38, 95% CI 1.13 to 1.69), large for gestational age (aOR 1.42, 95% CI 1.23 to 1.63), preterm birth (aOR 1.41, 95% CI 1.21 to 1.64), neonatal intensive care unit admission (aOR 1.42, 95% CI 1.12 to 1.78), neonatal hypoglycaemia (aOR 3.08, 95% CI 1.80 to 5.26) and jaundice (aOR 1.47, 95% CI 1.12 to 1.91). Further analyses showed no major differences in adverse pregnancy outcomes between IADPSG and non-IADPSG criteria. Conclusions GDM is consistently associated with adverse pregnancy, maternal and foetal outcomes, regardless of the diagnostic criteria used. These findings suggest no significant difference in risk between lower and higher blood glucose cut-offs used in GDM diagnosis.

28 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AAAishat F. Akomolafe
Aishat F. Akomolafe
BABushra M. Abdallah
Bushra M. Abdallah
FMFathima Mahmood
Fathima Mahmood
AEAmgad Mohamed Elshoeibi
Amgad Mohamed Elshoeibi
AAAisha Al-Khulaifi
Aisha Al-Khulaifi
TCTawanda Chivese
Tawanda Chivese
Background and Objective: Estimates of the prevalence of the autism spectrum disorder (ASD) in the Middle East and North Africa (MENA) region are not readily available, amid a lack of recent evidence. In this study, we estimated the prevalence of ASD in the MENA region by synthesising evidence from published studies in the region. Methods: In this systematic review and meta-analysis, we searched PubMed, EMBASE, Scopus, and CINAHL databases for studies which assessed ASD prevalence in the MENA region. Risk of bias was assessed using the Newcastle Ottawa scale. A bias-adjusted inverse variance heterogeneity meta-analysis model was used to pool prevalence estimates from included studies. Cochran’s Q statistic and the I 2 statistic were used to assess heterogeneity, and publication bias assessed using funnel and Doi plots. Results: A total of 3075 studies were identified, 16 studies of which met the inclusion criteria and involved 3,727,731 individuals. The studies were published during the period 2007-2022, and included individuals from Iran, Oman, Libya, Egypt, Kingdom of Saudi Arabia (KSA), Lebanon, United Arab Emirates (UAE), Bahrain and Qatar. Estimates of ASD prevalence ranged from 0.01% in Oman during the period June 2009-December 2009, to a high of 2.51% in the Kingdom of Saudi Arabia during the period December 2017-March 2018. The pooled prevalence of ASD was 0.13% (95% CI: 0.01% – 0.33%), with significant heterogeneity (I 2 = 99.8%). For Iran, the only country with multiple analysable studies, an overall prevalence of 0.06% (95% CI: 0.00 – 0.19, I2=97.5%, n= 6 studies) was found. A review of data from countries with repeated studies suggested that the prevalence of ASD is increasing. Conclusion: Estimates of the prevalence of ASD vary widely across the MENA region, from 0.01% in Oman to 2.51% in Saudi, with an overall prevalence of 0.13%. Existing data suggests a trend towards increasing prevalence in the region. More and better-quality research is needed to provide up to date ASD prevalence estimates. Registration: The protocol for this systematic review and meta-analysis was registered on the International Prospective Register of Systematic Reviews (PROSPERO) with registration ID CRD42024499837.

26 February 2025 in Clinical Case Reports
Verified
Journal Article
Open access
HAHussam Almasri
Hussam Almasri
EMElhassan Mahmoud
Elhassan Mahmoud
AAAshraf I. Ahmed
Ashraf I. Ahmed
HAHamad A. Alkorbi
Hamad A. Alkorbi
AAAiman Ahmed
Aiman Ahmed
BSBisher Sawaf
Bisher Sawaf
While Escherichia coli , Streptococcus , and Klebsiella species traditionally account for most cases of spontaneous bacterial peritonitis (SBP), atypical pathogens can be found. Salmonella , typically known for causing gastroenteritis, rarely manifests as SBP, while Brucella , a zoonotic pathogen, presents a unique challenge in the context of peritoneal infection. In this report, we present two cases of SBP caused by these atypical organisms. The first case involved a 58‐year‐old female with a history of hepatitis C‐related chronic liver disease and cryoglobulinemic vasculitis, who presented with SBP and hepatorenal syndrome‐associated acute kidney injury. Salmonella was identified in both ascitic fluid and blood cultures, but despite appropriate treatment, the patient experienced a fatal deterioration. The second case features a 52‐year‐old male with type 2 diabetes mellitus and newly diagnosed schistosomiasis, who presented with findings of decompensated liver cirrhosis and SBP. Brucella was isolated from ascitic fluid cultures, and the patient responded well to treatment. We aim to highlight the need for early recognition of atypical causes of SBP to improve management and outcomes.

1 January 2026 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
EMElhassan Mahmoud
Elhassan Mahmoud
YAYousra Ali
Yousra Ali
IOIbrahim M. Obeidat
Ibrahim M. Obeidat
SMSouraia Mezhoud
Souraia Mezhoud
RYRafie A. Yakoob
Rafie A. Yakoob
Upper gastrointestinal bleed (UGIB) is a significant and potentially life-threatening complication in renal transplant recipients, frequently associated with immunosuppressive therapy. We present a case of a 38-year-old male renal transplant recipient who experienced recurrent UGIB due to duodenal and gastric ulcers during the early postoperative period. His immunosuppressive regimen, initially consisting of antithymocyte globulin, steroids, tacrolimus, and mycophenolate mofetil (MMF), was adjusted multiple times in response to persistent bleeding episodes. Despite numerous endoscopic, radiological, and surgical interventions, his condition necessitated further immunosuppressive modulation, including cessation of MMF and introduction of belatacept, which ultimately stabilized his gastrointestinal condition. This case underscores the complexities of managing UGIB in renal transplant recipients under immunosuppressive therapy and highlights the need for a tailored multidisciplinary approach to optimize outcomes while preserving graft function.

27 August 2025 in Health Science Reports
Verified
Journal Article
Open access
AAAshraf I. Ahmed
Ashraf I. Ahmed
EMElhassan Mahmoud
Elhassan Mahmoud
MKMuhammad Zain Kaleem
Muhammad Zain Kaleem
SASara Ali
Sara Ali
HFHabib H. Farooqui
Habib H. Farooqui
TCTawanda Chivese
Tawanda Chivese
Background and Aims: Understanding the determinants of humoral immunity following COVID‐19 infection is essential for guiding vaccination and public health strategies. This study aimed to investigate the association between cycle threshold (Ct) values and SARS‐CoV‐2‐specific antibody reactivity 1 month after recovery in a Middle Eastern cohort, and to identify other contributing factors. Methods: A case‐control study was conducted among COVID‐19 patients registered in the Qatar Biobank between March and September 2020. Cases were defined as individuals with detectable anti‐SARS‐CoV‐2 antibodies 1‐month post‐recovery, while controls lacked antibody reactivity. Demographics, comorbidities, Ct values, and disease severity were collected at baseline. Logistic regression was used to analyze factors associated with antibody reactivity, with results adjusted for key covariates. Results: Among 225 participants, 177 (78.7%) exhibited reactive anti‐SARS‐CoV‐2 IgG antibodies 1‐month post‐recovery. Among participants with reactive antibodies, 74.0% were from severe and critical cases. Lower Ct values (< 20), indicating higher viral load, were associated with increased odds of antibody reactivity (OR 2.03, 95% CI 0.97–4.24, p = 0.059). Male gender was significantly associated with antibody reactivity (OR 3.24, 95% CI 1.53–6.89, p = 0.002), while disease severity and BCG vaccination status showed no significant association. Conclusion: Ct values and male gender may serve as significant predictors of antibody‐mediated immunity to COVID‐19 infection. Larger studies are needed to validate these findings, identify vulnerable individuals who may benefit from booster vaccination, and explore their relevance to other respiratory pathogens.

28 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AAAishat F. Akomolafe
Aishat F. Akomolafe
FMFathima Mahmood
Fathima Mahmood
BABushra M. Abdallah
Bushra M. Abdallah
AEAmgad Mohamed Elshoeibi
Amgad Mohamed Elshoeibi
EMElhassan Mahmoud
Elhassan Mahmoud
TCTawanda Chivese
Tawanda Chivese
Background and Objectives: The etiology of autism spectrum disorder (ASD) is poorly understood, with sparse data from the Middle East and North Africa (MENA) region, which has a unique climate and socio-epidemiological setting. This research investigated the developmental (early life) risk factors associated with ASD in the MENA region. Methods: In this systematic review and meta-analysis, we searched for observational studies, which carried out adjusted analyses for ASD risk factors in the MENA region, in PubMed, Embase, Scopus, and CINAHL databases. We analyzed associations between ASD and factors related to conception, inheritance, maternal morbidity during pregnancy and adverse pregnancy outcomes. After study quality assessment, meta-analyses for each risk factor were carried out using the bias-adjusted inverse variance heterogeneity model. Heterogeneity was assessed using I 2 and publication bias using Doi and funnel plots. Results: The systematic review included 19 case control studies from eight countries within the MENA region. In overall synthesis, male sex (OR=3.27, 95% CI: 2.39-4.48, I2 = 40.9%), family history of ASD (OR=2.98, 95% CI: 0.51-17.31, I2 = 85.0%), and consanguinity (OR= 1.77, 95% CI: 1.38-2.28, I2 = 57.1%) were associated with ASD. Although with limited studies, a review of the literature showed some possible associations between ASD and gestational diabetes, gestational hypertension, macrosomia, NICU admission, respiratory distress syndrome, cesarean delivery, gestational age, and older maternal age. Conclusion: These findings confirm the association between male sex, family history of ASD and consanguinity with ASD, potentially suggesting some inherited mechanism in the etiology of ASD in the MENA region. Some maternal co-morbidities during pregnancy and adverse pregnancy outcomes may contribute to ASD risk in the MENA region, although more studies are needed in the region. Registration: The protocol for this systematic review and meta-analysis is registered on the International Prospective Register of Systematic Reviews (PROSPERO) with registration ID CRD42024499837.